1h Free Analyst Time
The Albumin Market size was estimated at USD 6.15 billion in 2022, USD 6.53 billion in 2023, and is expected to grow at a CAGR of 6.56% to reach USD 10.23 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Albumin is a complex and versatile protein that constitutes approximately 50%-60% of the total protein content in human blood plasma. It is synthesized predominantly by the liver and plays an essential role in physiological functions, such as maintaining osmotic pressure, binding and transporting various molecules, and acting as an antioxidant. Albumin's importance lies in its multifaceted contributions to overall health and well-being, making it a significant biomarker for assessing an individual's disease risk and clinical status. The growing usage of albumin in clinical settings for the treatment of burns and the rising prevalence of liver diseases where patients require a regular supply of HSA to maintain proper health functions has accelerated the use of albumin worldwide. However, risks associated with contamination and transmission of infectious agents in HSA products sourced from pooled human plasma donations impact albumin usage. Stringent regulatory guidelines for product approvals in different regions also affect the commercialization of albumin. Market players are investing in research and development initiatives that explore innovative production methods, such as plant-based expression systems or microbial fermentation processes capable of yielding high-quality albumin products at lower costs. New opportunities are emerging with the evolution of biotechnological advancements that enable the production of recombinant human albumins (rHA) through genetic engineering techniques.
Regional Insights
The Americas albumin market is advancing, driven by investments by pharmaceutical companies investing heavily in research and technology to develop advanced albumin formulations. Regulatory bodies such as the Food and Drug Administration (FDA) in the U.S. enforce strict quality control measures to assure safety standards of albumin. The FDA has also given approval for certain albumin products in recent years. Technological advancements such as recombinant HSA production are being researched across the U.S. and Canada to potentially reduce dependency on human plasma donations for albumin supply. The Asian albumin market is experiencing rapid expansion fueled by increasing healthcare expenditure and improving medical infrastructure in emerging countries demanding plasma-derived products for therapeutic purposes, including liver disease treatment, surgeries, and intensive care support. Europe is a potential contributor to the global albumin market, with an established consumption base and robust manufacturing capabilities. The use of albumin in Europe is primarily focused on critical care applications such as sepsis management, volume replacement therapies, and therapeutic plasma exchange procedures. The European Medicines Agency (EMA) regulates the production and distribution of albumin within the European Union (EU).FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Albumin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Albumin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Albumin Market, highlighting leading vendors and their innovative profiles. These include Aadi Bioscience, Inc., Agilent Technologies, Inc., Akron Biotech, Atlantis Bioscience Pte Ltd., Avantor Inc., Baxter International Inc., Becton, Dickinson and Company, Bio Products Laboratory Ltd., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biogenix Inc. Pvt. Ltd., Biophyll GmbH, Biorbyt Ltd., Biowest SAS, Boston BioProducts Inc., Bristol-Myers Squibb Company, CENTURION PHARMA Ilaç Sanayi ve Ticaret A.S., China Biologic Products Holdings, Inc. by Taibang Biologic Group, CSL Limited, Dem Ilaç, F. Hoffmann-La Roche AG, GC Biopharma Corp., Glentham Life Sciences Limited, Grifols SA, InVitria, InVitroCare Inc., Kedrion S.p.A, Kraeber & Co. GmbH, Lazuline Biotech Private Limited, LGC Science Group Holdings Limited, Merck KGaA, Midas Pharma GmbH, Octapharma AG, Promega Corporation, Prospec-Tany Technogene Ltd., Rockland Immunochemicals Inc., Rocky Mountain Biologicals, LLC, Sartorius AG, Serion GmbH, SK Plasma, Takeda Pharmaceuticals Company Limited, Thermo Fisher Scientific Inc., Ventria Bioscience Inc., and VitroScient.Market Segmentation & Coverage
This research report categorizes the Albumin Market to forecast the revenues and analyze trends in each of the following sub-markets:- Source
- Animal Sources
- Bovine Serum Albumin
- Human Serum Albumin
- Ovalbumin
- Plant Sources
- Animal Sources
- Type
- Non-Recombinant
- Recombinant
- Application
- Cosmetic Ingredient
- Culture Media
- Drug Delivery
- Food Ingredient
- Therapeutic
- Vaccine Ingredient
- End User
- Pharmaceutical & Biotechnology
- Research Institutes
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as
- What is the market size and forecast of the Albumin Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Albumin Market?
- What are the technology trends and regulatory frameworks in the Albumin Market?
- What is the market share of the leading vendors in the Albumin Market?
- Which modes and strategic moves are suitable for entering the Albumin Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Albumin Market, by Source
7. Albumin Market, by Type
8. Albumin Market, by Application
9. Albumin Market, by End User
10. Americas Albumin Market
11. Asia-Pacific Albumin Market
12. Europe, Middle East & Africa Albumin Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
List of Figures
List of Tables
Companies Mentioned
- Aadi Bioscience, Inc.
- Agilent Technologies, Inc.
- Akron Biotech
- Atlantis Bioscience Pte Ltd.
- Avantor Inc.
- Baxter International Inc.
- Becton, Dickinson and Company
- Bio Products Laboratory Ltd.
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- Biogenix Inc. Pvt. Ltd.
- Biophyll GmbH
- Biorbyt Ltd.
- Biowest SAS
- Boston BioProducts Inc.
- Bristol-Myers Squibb Company
- CENTURION PHARMA İlaç Sanayi ve Ticaret A.Ş.
- China Biologic Products Holdings, Inc. by Taibang Biologic Group
- CSL Limited
- Dem İlaç
- F. Hoffmann-La Roche AG
- GC Biopharma Corp.
- Glentham Life Sciences Limited
- Grifols SA
- InVitria
- InVitroCare Inc.
- Kedrion S.p.A
- Kraeber & Co. GmbH
- Lazuline Biotech Private Limited
- LGC Science Group Holdings Limited
- Merck KGaA
- Midas Pharma GmbH
- Octapharma AG
- Promega Corporation
- Prospec-Tany Technogene Ltd.
- Rockland Immunochemicals Inc.
- Rocky Mountain Biologicals, LLC
- Sartorius AG
- Serion GmbH
- SK Plasma
- Takeda Pharmaceuticals Company Limited
- Thermo Fisher Scientific Inc.
- Ventria Bioscience Inc.
- VitroScient
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | March 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 6.53 Billion |
| Forecasted Market Value ( USD | $ 10.23 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 44 |
